Department of Bio and Brain Engineering, KAIST, Daejeon, 34141, Korea.
Department of Neurosurgery, Brain Tumor Center, Severance Hospital, Yonsei University College of Medicine, Seoul, 03722, Korea.
Sci Rep. 2018 Mar 15;8(1):4608. doi: 10.1038/s41598-018-22681-3.
Glioblastoma multiforme (GBM) is the most common brain tumor with very aggressive and infiltrative. Extracellular matrix (ECM) plays pivotal roles in the infiltrative characteristics of GBM. To understand the invasive characteristic of GBM, it is necessary to study cell-ECM interaction in the physiologically relevant biomimetic model that recapitulates the GBM-specific ECM microenvironment. Here, we propose biomimetic GBM-specific ECM microenvironment for studying mode and dynamics of glioblastoma cell invasion. Using tissue decellularization process, we constructed a patient tissue-derived ECM (pdECM)-based three-dimensional in vitro model. In our model, GBM cells exhibited heterogeneous morphology and altered the invasion routes in a microenvironment-adaptive manner. We further elucidate the effects of inhibition of ECM remodeling-related enzymatic activity (Matrix metalloproteinase (MMP) 2/9, hyaluronan synthase (HAS)) on GBM cell invasion. Interestingly, after blocking both enzyme activity, GBM cells underwent morphological transition and switch the invasion mode. Such adaptability could render cell invasion resistant to anti-cancer target therapy. There results provide insight of how organ-specific matrix differentially regulates cancer cell phenotype, and have significant implications for the design of matrix with appropriate physiologically relevant properties for in vitro tumor model.
多形性胶质母细胞瘤(GBM)是最常见的脑肿瘤,具有非常侵袭性和浸润性。细胞外基质(ECM)在 GBM 的浸润特征中起着关键作用。为了了解 GBM 的浸润特征,有必要在生理相关的仿生模型中研究细胞-ECM 相互作用,该模型再现了 GBM 特异性 ECM 微环境。在这里,我们提出了仿生 GBM 特异性 ECM 微环境,用于研究神经胶质瘤细胞浸润的模式和动力学。我们使用组织去细胞化过程构建了基于患者组织衍生细胞外基质(pdECM)的三维体外模型。在我们的模型中,GBM 细胞表现出异质形态,并以微环境适应性的方式改变了入侵途径。我们进一步阐明了抑制细胞外基质重塑相关酶活性(基质金属蛋白酶(MMP)2/9、透明质酸合酶(HAS))对 GBM 细胞侵袭的影响。有趣的是,在阻断两种酶的活性后,GBM 细胞经历了形态转变并切换了侵袭模式。这种适应性可以使细胞侵袭对抗癌靶向治疗产生抗性。这些结果提供了关于特定器官基质如何差异调节癌细胞表型的见解,并对设计具有适当生理相关特性的用于体外肿瘤模型的基质具有重要意义。